SMRs (observed deaths) by cumulative exposure, for haematopoietic cancer mortality, by sex, 10 year lag
| Cause | 0 (lagged out) | >0–1199 ppm-days | 1200–3679 ppm-days | 3680–13499 ppm-days | 13500+ ppm-days |
|---|---|---|---|---|---|
| *95 % CI 1.02 to 4.67. | |||||
| Males (n = 7645) | |||||
| All haematopoietic | 1.15 (7) | 0.63 (5) | 0.87 (5) | 1.10 (7) | 1.46 (13) |
| NHL | 2.09 (4) | 0.61 (2) | 0.88 (2) | 0.79 (2) | 2.37* (8) |
| Hodgkin’s | 1.07 (1) | 0 (0) | 3.44 (1) | 3.44 (1) | 5.71 (2) |
| Leukaemia | 0.41 (1) | 1.01 (3) | 0.0 (0 | 1.70 (4) | 0.60 (2) |
| Myeloma | 1.56 (1) | 0 (0) | 1.94 (2) | 0 (0) | 0.54 (1) |
| Females (n = 9885) | |||||
| All haematopoietic | 0.31 (2) | 1.04 13) | 1.38 (10) | 1.06 (9) | 0.46 (3) |
| NHL | 1.88 (1) | 0.78 (4) | 1.32 (4) | 0.56 (2) | 0.37 (1) |
| Hodgkin’s | 0 (0) | 0 (0) | 0 (0) | 3.70 (1) | 0 (0 |
| Leukaemia | 0.49 (1) | 1.57 (7) | 1.56 (4) | 1.02 (3) | 0 (0) |
| Myeloma | 0 (0) | 0.85 (2) | 1.42 (2) | 1.76 (3) | 1.43 (2) |